iCAD gets FDA nod for Second Look 200

Computer-aided detection developer iCAD has received Food and Drug Administration clearance for its Second Look 200 breast cancer CAD system. The product will cost under $70,000, and is designed to make CAD available to smaller breast cancer centers, according to the Nashua, NH-based firm.

Second Look 200 can analyze up to 15 cases per day and fits on a countertop. The combination of Second Look 200 with iCAD's Version 6.0 cancer detection software offers up to 94% sensitivity for all breast cancers, according to the vendor. iCAD's resellers are now accepting orders for Second Look 200, which will also be available on a fee-per-procedure basis with the company's ClickCAD program.

By AuntMinnie.com staff writers
June 3, 2004

Related Reading